FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113883.3.1444.5.235.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.1444.5.235/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.235 |
| Version | 20230622 |
| Status | active |
| Date | 2023-06-22T01:00:59-04:00 |
| Name | BRCA2Testing |
| Title | BRCA2 Testing |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA2 by Immune Stain.) |
No resources found
| CodeSystem | |
| cpt | Current Procedural Terminology (CPT®) |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.3.1444.5.235",
"meta": {
"versionId": "7",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "American Society of Clinical Oncology Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-07-03"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-06-22"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.235",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.3.1444.5.235"
}
],
"version": "20230622",
"name": "BRCA2Testing",
"title": "BRCA2 Testing",
"status": "active",
"date": "2023-06-22T01:00:59-04:00",
"publisher": "American Society of Clinical Oncology Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for the procedure of BRCA2 testing.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a procedure for BRCA2 testing.),(Exclusion Criteria: Excludes concepts related to BRCA2 by Immune Stain.)",
"compose": {
"include": [
{
"valueSet": [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.206"
]
}
]
},
"expansion": {
"identifier": "urn:uuid:59be54d3-361b-4623-a85a-7c718dabb367",
"timestamp": "2025-05-23T21:57:17-04:00",
"total": 3,
"contains": [
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "81167",
"display": "BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "81216",
"display": "BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis"
},
{
"system": "http://www.ama-assn.org/go/cpt",
"version": "2025",
"code": "81217",
"display": "BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; known familial variant"
}
]
}
}